Medical Holding Corporation Confirms Compliance for Continued Nasdaq Listing, Focuses on QUELIMMUNE and Organ-Sparing Therapies

  • Kevin Chung

Press/Media

Period2 Jul 2025

Media coverage

1

Media coverage